Biogen (BIIB) Other Non-Current Assets (2016 - 2025)
Biogen has reported Other Non-Current Assets over the past 17 years, most recently at $750.6 million for Q4 2025.
- Quarterly results put Other Non-Current Assets at $750.6 million for Q4 2025, up 33.92% from a year ago — trailing twelve months through Dec 2025 was $750.6 million (up 33.92% YoY), and the annual figure for FY2025 was $750.6 million, up 33.92%.
- Other Non-Current Assets for Q4 2025 was $750.6 million at Biogen, up from $729.7 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for BIIB hit a ceiling of $2.5 billion in Q2 2021 and a floor of $559.1 million in Q1 2025.
- Median Other Non-Current Assets over the past 5 years was $929.8 million (2023), compared with a mean of $1.2 billion.
- Biggest five-year swings in Other Non-Current Assets: surged 114.31% in 2021 and later tumbled 53.21% in 2023.
- Biogen's Other Non-Current Assets stood at $1.9 billion in 2021, then dropped by 21.15% to $1.5 billion in 2022, then tumbled by 51.28% to $745.0 million in 2023, then dropped by 24.77% to $560.5 million in 2024, then soared by 33.92% to $750.6 million in 2025.
- The last three reported values for Other Non-Current Assets were $750.6 million (Q4 2025), $729.7 million (Q3 2025), and $637.7 million (Q2 2025) per Business Quant data.